Yuen, Hiu-Fung <br/><br/>
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.  [electronic resource] 

 -  Cancer science  Jun 2012 
 - 1145-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2012.02252.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Morphogenetic Protein 6--genetics<br/>Bone Morphogenetic Proteins--genetics<br/>Carcinoma, Squamous Cell--genetics<br/>Carrier Proteins--genetics<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--metabolism<br/>Disease Progression<br/>Esophageal Neoplasms--genetics<br/>Female<br/>Genetic Markers--genetics<br/>Humans<br/>Inhibitor of Differentiation Protein 1--metabolism<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--metabolism<br/>RNA Interference<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering<br/>Signal Transduction<br/>Urinary Bladder Neoplasms--metabolism